Euro Roundup: MHRA commission makes recommendations on AI regulatory framework in the UK
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has received 44 recommendations for a new AI regulatory framework. The commission suggests shifting from one-off pre-market assessments to a lifecycle-based approach to better manage AI-enabled medical devices.
Why it matters
This shift represents a significant change in how healthcare technology is governed, aiming to balance patient safety with the need for rapid innovation in medical AI.
The complete guide to formulating an effective global regulatory strategy for medical devices, created and curated by experts.
Our new assessment-based certificate is designed for early-career regulatory professionals.
A bimonthly, peer-reviewed publication providing in-depth, evidence-based content, exclusive to RAPS members.
Join one of the many groups where you can pursue your regulatory passions with people who share your interests.
Navigating the regulatory job market? These resources can help.
A commission set up by the Medicines and Healthcare products Regulatory Agency (MHRA) has shared 44 recommendations about the future regulatory framework for AI in the UK.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in